MedTrace Logo

Expectations and Beliefs of Transgender People Regarding Hormonal Treatment

NCT05474768 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2022-07-26

No results posted yet for this study

Summary

Hormonal treatment of gender dysphoria can have repercussions on metabolism, cardiovascular system and fertility and represents à potential oncological risk. According to the recommendations of the Endocrine society. Therefore, initial assessment and follow-up visits are necessary and must be carried out to avoid the apparition of potentially undesirable effects.

Conditions

  • Transgenderism

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-02
Primary Completion
2022-11-30
Completion
2023-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05474768 on ClinicalTrials.gov